Dynamic contrast-enhanced MRA at 1.5 T for detection of arteriovenous shunting before and after Onyx embolization of cerebral arteriovenous malformations

J Neuroimaging. 2013 Oct;23(4):514-7. doi: 10.1111/j.1552-6569.2012.00780.x. Epub 2013 Jan 14.

Abstract

Background: Conventional non-invasive angiographic techniques for evaluating cerebral Arteriovenous Malformations (cAVMs) after embolization treatment are limited by their inability to acquire time-resolved images. We describe the use of dynamic contrast-enhanced magnetic resonance angiography (MRA) in the evaluation of residual arteriovenous shunting in cAVMs following Onyx embolization.

Methods: Six subjects who underwent multimodal MR imaging including dynamic MRA after different stages of endovascular treatment with Onyx were included. Each MRA was assessed for the presence of residual arteriovenous shunting. The results were compared with digital subtraction angiography (DSA).

Results: Mean age was 41 years (range, 25-63) and the mean maximum AVM diameter was 5.3 cm (range, 4.7-6.0). Fourteen dynamic MRA were performed using a 1.5 T scanner. Arteriovenous shunting was detected in thirteen of fourteen patients by both dynamic MRA and DSA, with complete agreement between the two techniques. The only MRA without detectable residual arteriovenous shunting was for a subject who had complete treatment with no residual cAVM as confirmed by the DSA images.

Conclusions: Dynamic contrast-enhanced MRA is a promising non-invasive modality in identifying residual arteriovenous shunting after different stages of AVM embolization, achieving 100% agreement in this small study. Embolization with Onyx caused no significant image artifact.

Keywords: Cerebral arteriovenous malformation; MRI; Onyx; TRICKS.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Contrast Media
  • Dimethyl Sulfoxide / therapeutic use*
  • Embolization, Therapeutic / methods*
  • Female
  • Gadolinium DTPA*
  • Hemostatics / therapeutic use
  • Humans
  • Image Enhancement / methods*
  • Intracranial Arteriovenous Malformations / pathology*
  • Intracranial Arteriovenous Malformations / therapy*
  • Magnetic Resonance Imaging, Interventional / methods*
  • Male
  • Middle Aged
  • Polyvinyls / therapeutic use*
  • Treatment Failure
  • Treatment Outcome

Substances

  • Contrast Media
  • Hemostatics
  • Onyx copolymer
  • Polyvinyls
  • Gadolinium DTPA
  • Dimethyl Sulfoxide